Location History:
- Guangzhou, CN (2018 - 2019)
- Guangdong, CN (2020 - 2021)
Company Filing History:
4 out of 3,097 
1 out of 249 
1 out of 2 
Years Active: 2018-2021
Title: Innovations by Inventor Xiaomei Ren in Pharmaceutical Science
Introduction
Xiaomei Ren is a notable inventor based in Guangdong, China, who has made significant contributions to the field of pharmaceutical sciences. With a total of four patents to her name, Ren has focused her research on developing innovative therapies for various hyper-proliferative diseases.
Latest Patents
Ren's most recent patents are groundbreaking in their applications for treating complex medical conditions. One patent focuses on FGFR kinase inhibitors and their pharmaceutical uses. These inhibitors target the Fibroblast Growth Factor Receptor kinase and their derivatives are proposed for the treatment of several diseases such as retinopathy, psoriasis, rheumatoid arthritis, osteoarthritis, and more.
Another notable patent involves substituted quinolone derivatives and their pharmaceutical compositions. This innovation provides a method for preparing anti-tumor drugs, particularly effective against hyper-proliferative diseases. It highlights the potential of these derivatives as protein kinase inhibitors that can suppress the activity of AXL protein kinase, proving crucial for inhibiting the proliferation and invasion of tumor cells.
Career Highlights
Throughout her career, Xiaomei Ren has worked with prestigious institutions, notably the Shanghai Institute of Materia Medica and the Guangzhou Institutes of Biomedicine and Health, both part of the Chinese Academy of Sciences. Her research in these leading institutions has bolstered her contributions to innovative drug development.
Collaborations
Ren has collaborated with esteemed professionals in her field, including her coworkers Ke Ding and Zhengchao Tu. These partnerships have fostered a collaborative environment that has led to significant advancements in her research projects and innovations.
Conclusion
Xiaomei Ren stands out as an influential inventor in the pharmaceutical industry, dedicated to addressing complex health challenges through her innovative patents. Her work emphasizes the importance of collaboration and research in driving forward medical science, and her contributions hold promise for future advancements in treating hyper-proliferative diseases.